
Opinion|Videos|January 17, 2025
Patient Selection for Port Delivery System
Panelists discuss how patients experiencing a high treatment burden with frequent anti-VEGF injections every 4-8 weeks are optimal candidates for the port delivery system, which can help reduce their number of clinic visits while maintaining therapeutic effectiveness.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Which patients are ideal candidates for this anti-VEGF delivery method?
- Patients with frequent anti-VEGF treatment burden (4-8 weeks)
Advertisement
Related to this article

In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.

Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.

The RMAT designation opens the door to a faster development pathway for EO2002 as a minimally invasive alternative to corneal transplantation, while Emmecell also advances a cell therapy for geographic atrophy.

Andrew G. Lee, MD, and Drew Carey, MD, discuss findings from a retrospective study examining ischemic stroke risk in patients with non-arteritic anterior ischemic optic neuropathy and the implications for vascular risk factor management.

What the approval of a second targeted biologic means for patients, practice, and the evolving TED treatment landscape
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
2
AAO 2026: MCO-010 sustains vision gains in RP through 4 years
3
AAO 2026: What the first whole eye transplant has taught surgeons
4
AAO 2026: What the evidence really shows about nutrition and the eye
5


